This dual-peptide formulation combines Semax (a synthetic ACTH analogue heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro) with Selank (a tuftsin analogue, Thr-Lys-Pro-Arg-Pro-Gly-Pro). Both peptides have been developed and researched extensively in the context of neurological function.
Semax has been studied for BDNF expression modulation and cognitive research endpoints. Selank has been investigated in anxiolytic, immune-modulation, and memory research models. The combination is of interest to researchers studying synergistic neuropeptide interactions.
assets/coa/semax-selank-coa.pdf<embed src="../assets/coa/semax-selank-coa.pdf" class="coa-embed" type="application/pdf"/>